ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,767.50
0.10%
S&P ASX All Technology
3,137.90
0.55%
Brent Oil
84.85
0.00%
US Dollar vs AUD
1.49566
0.00%
Bitcoin
60,984.31
1.12%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Eurobio Scientific (ALERS) Share Price

Eurobio Scientific

Eurobio Scientific (ALERS)

EU
13.82
-0.08
(-0.58%)
Closed 30 June 1:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
13.82
Bid
13.78
Offer
14.30
Volume
12,505
13.80 Day's Range 14.20
12.20 52 Week Range 18.10
Market Cap
-
Previous Close
13.90
Open
14.00
Last Trade
28
@
13.82
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
4,413
Shares Outstanding
10,248,871
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About Eurobio Scientific

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.eurobio-scientific.com
Headquarters
Les Ulis, Essonne, Fra
Founded
1970
Eurobio Scientific is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALERS. The last closing price for Eurobio Scientific was 13.90 €. Over the last year, Eurobio Scientific shares have traded in a share price range of 12.20 € to 18.10 €.

Eurobio Scientific currently has 10,248,871 shares in issue.

ALERS Latest News

More News

EUROBIO SCIENTIFIC SIGNE UN ACCORD POUR L'ACQUISITION DU TEST D'EXPRESSION GÉNIQUE POUR LE CANCER DU SEIN ENDOPREDICT®

EUROBIO SCIENTIFIC SIGNE UN ACCORD POUR L'ACQUISITION DU TEST D'EXPRESSION GÉNIQUE POUR LE CANCER DU SEIN ENDOPREDICT® EUROBIO SCIENTIFIC SIGNE UN ACCORD POUR L'ACQUISITION DU TEST...

08 May 2024
GlobeNewswire Inc.

Eurobio Scientific : mise à disposition du rapport financier annuel 2023

Eurobio Scientific : mise à disposition du rapport financier annuel 2023 MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2023 Paris, le 26 avril 2024 – 17h45 Eurobio Scientific...

27 April 2024
GlobeNewswire Inc.

Eurobio Scientific : Rapport Financier Annuel 2023

Eurobio Scientific : Rapport Financier Annuel 2023 Eurobio Scientific : Rapport Financier Annuel 2023 Pièce jointe EBS_RFA_2023

27 April 2024
GlobeNewswire Inc.

EUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS

EUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS 2023 ANNUAL RESULTS Growth in Core Business and strategic deployment Core business1 revenues up 39% to €130m proprietary products account for 30% of...

11 April 2024
GlobeNewswire Inc.

Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP

Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP Continued total year growth in core business revenues, up...

31 January 2024
GlobeNewswire Inc.

Eurobio Scientific : BILAN SEMESTRIEL S2 DU CONTRAT DE LIQUIDITE

Eurobio Scientific : BILAN SEMESTRIEL S2 DU CONTRAT DE LIQUIDITE BILAN SEMESTRIEL S2 DU CONTRAT DE LIQUIDITE Paris, le 17 janvier 2024 – 17h45 Au titre du contrat de liquidité portant sur...

18 January 2024
GlobeNewswire Inc.

Eurobio Scientific : réduction de capital par annulation d’actions auto-détenues

Eurobio Scientific : réduction de capital par annulation d’actions auto-détenues Réduction de capital par annulation d’actions auto-détenues Annulation de 694 300 actions auto-détenues, soit...

10 January 2024
GlobeNewswire Inc.

Eurobio Scientific : NOMINATION DE CATHERINE COURBOILLET EN TANT QU’ADMINISTRATRICE INDEPENDANTE

Eurobio Scientific : NOMINATION DE CATHERINE COURBOILLET EN TANT QU’ADMINISTRATRICE INDEPENDANTE NOMINATION DE CATHERINE COURBOILLET EN TANT QU’ADMINISTRATRICE INDEPENDANTE Paris, le 7...

08 November 2023
GlobeNewswire Inc.
Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.38-2.6760563380314.214.513.8268614.06097699DE
4-0.66-4.5580110497214.4815.113.8412314.59471796DE
12-1.98-12.531645569615.816.4813.8441314.93521824DE
26-2.18-13.6251618.113.8483815.86713845DE
52-0.08-0.57553956834513.918.112.2550415.52069907DE
156-4.88-26.096256684518.729.7612.22388719.84026474DE
26010.47312.5373134333.3557.43.085991514.09092348DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LDROLode Resources Ltd
AUD 0.005
(400.00%)
49.26k
TKMOTrek Metals Limited
AUD 0.002
(100.00%)
277.78k
IBGOIronbark Zinc Limited
AUD 0.002
(100.00%)
1.25M
BFCBeston Global Food Company Limited
AUD 0.003
(50.00%)
8.94M
TD1Tali Digital Limited
AUD 0.0015
(50.00%)
1.05M
RAGORagnar Metals Limited
AUD 0.001
(-75.00%)
1M
ACMOAAustralian Critical Minerals Ltd
AUD 0.013
(-56.67%)
45k
AEVOAvenira Limited
AUD 0.001
(-50.00%)
3M
GRLOGodolphin Resources Limited
AUD 0.001
(-50.00%)
3M
HYTOHyTerra Ltd
AUD 0.011
(-35.29%)
1.2M
PENPeninsula Energy Ltd
AUD 0.1025
(0.00%)
77.12M
SYASayona Mining Limited
AUD 0.036
(-2.70%)
59.44M
ADNAndromeda Metals Limited
AUD 0.016
(-11.11%)
49.06M
IMUImugene Limited
AUD 0.057
(5.56%)
45.01M
SGRStar Entertainment Group Limited
AUD 0.50
(2.56%)
40.45M

Discussion

View Full Feed
plexrec plexrec 5 minutes ago
Xena--" but what if the patients didn't want more media"--and why wouldn't they ?? spread the word the drug works--help other people with the disease !!!!
AVXL
georgejjl georgejjl 6 minutes ago
You seemed to have forgotten the two participants in the Phase 2b/3

An Australian TV news interview of several Alzheimer's patients who had astonishing improvements from participating in drug trial of Anavex 2-73.

https://www.youtube.com/watch?v=U2yDXwNnCTI
AVXL
dmb2 dmb2 6 minutes ago
Inspections tend to be later stage activities since the inspections are mostly done against the work that has been submitted, hearing inspections being discussed is a good thing in my opinion. I think since MHRA has not communicated review stage progress to NWBO, which I do not understand but that i
NWBO
Hawk Thew Hawk Thew 6 minutes ago
Low Float approx 14 million shares.
LRGR
HGilS HGilS 7 minutes ago
Incredible what you can see with goggles Or was it Google?
ELTP
Nemesis18 Nemesis18 7 minutes ago
LC, the NICE will never implicitly endorse this cancer treatment by way of granting any degree of reimbursement, as it will open them and the NHS to future litigation issues.
NWBO
Ski22 Ski22 8 minutes ago
I think you’re wrong. If it does a 40/1 R/S the O/S will be 40 million. It will get pumped hard the first couple of days after a R/S and with only 40M shares it will fly. I’m not saying it will stay there but being a meme stock with only 40M it will go!
FFIE
Nightdaytrader Nightdaytrader 8 minutes ago
Hard to believe Erhc let all these years pass buy and couldn’t cut a deal, and get something of value, anything, for shareholders, for eez blocks 4 and 11. (Plus two more 15% blocks)..
ERHE
rikkie rikkie 8 minutes ago
Patience !🤔
LWLG
rooster rooster 8 minutes ago
How much has Joe really defended the Jews over you Jew hating Hamas loving leftist
ExtremelyBullishZig ExtremelyBullishZig 9 minutes ago
It is?
AVXL
bradford86 bradford86 10 minutes ago
Would like to see this recentl price action post debate continue
FNMA
dennisdave dennisdave 10 minutes ago
we believe MHRA is following the 150 day process but we do not have confirmation at what point in the process would nwbo be receiving that confirmation? with the RFI?
NWBO
BGOOD1 BGOOD1 10 minutes ago
It's been a long wait. I hope July is the payoff
FBEC
DewDiligence DewDiligence 10 minutes ago
SOLV’s “AI play”—>heath-information systems segment:

https://finance.yahoo.com/news/solventum-introduces-denials-prevention-solution-130000721.html

Heath-information systems comprised 16% of SOLV’s overall (pro forma) sales in 1Q24 (#msg-174387294), but SOLV expects thi
SOLV
rooster rooster 10 minutes ago
Obama hasn’t left that’s the problem and that’s why he’ll do whatever it takes to keep demented joe in office
Nemesis18 Nemesis18 11 minutes ago
Imo there never was a formal procedural RFI, as this application had derailed so significantly, that it
became a mute point.
A review became an investigation along time ago
NWBO
tjvs tjvs 12 minutes ago
Tsoi great company spinoff coming very shortly.
TSOI
Eli's Gone Eli's Gone 12 minutes ago
https://x.com/PGATOURComms/status/1807139208848662985
Nightdaytrader Nightdaytrader 12 minutes ago
Hard to believe Erhc let all these years pass buy and couldn’t cut a deal, and get something of value, anything, for shareholders, for eez blocks 4 and 11. (Plus two more 15% blocks)..
ERHE
leverage102 leverage102 13 minutes ago
NSAV $$$$$

https://x.com/NSAV_Tech

https://www.thealley.io/
NSAV
janice shell janice shell 13 minutes ago
Charlottesville...and Biden says that Trump defended neo-Nazis and white supremacists "coming out of the forest with swastikas and torches."

Really? But Trump did exactly that. I posted articles from The Hill--not exactly a leftist publication--and from ABC:

https://inv
learningcurve2020 learningcurve2020 13 minutes ago
I've been wondering when someone would chime in on old Les the Lawyer's Advent presentation. Don't blame you for not. Why do you suppose they let him do that part? Eye rolls.

So if approval ever occurs and when NICE finally asks them to sharpen the pencil with a steep discount, at l
NWBO
dmb2 dmb2 14 minutes ago
Flipper, I am with you, it makes no sense to call it a 150 day process if every review has to incl an addl 60 day RFI off the clock period, then it is a 210 day process. I understand there is no PDUFA date but the UK has spent a lot of effort to establish themselves as a choice market to do biotech
ASM NWBO

Your Recent History

EU
ALERS
Eurobio Scientific
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved